These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 1782303)
1. The pro-drug sulindac may reduce the risk of intestinal damage associated with the use of conventional non-steroidal anti-inflammatory drugs. Davies GR; Rampton DS Aliment Pharmacol Ther; 1991 Dec; 5(6):593-8. PubMed ID: 1782303 [TBL] [Abstract][Full Text] [Related]
3. Effect of a selective nonsteroidal anti-inflammatory inhibitor of cyclooxygenase-2 on the small bowel of rats. Leite AZ; Sipahi AM; Damião AO; Garcez AT; Buchpiguel CA; Lopasso FP; Lordello ML; Agostinho CL; Laudanna AA Braz J Med Biol Res; 2004 Mar; 37(3):333-6. PubMed ID: 15060699 [TBL] [Abstract][Full Text] [Related]
4. Comparison of polysucrose 15000, 51Cr-labelled ethylenediaminetetraacetic acid, and 14C-mannitol as markers of intestinal permeability in man. Oman H; Blomquist L; Henriksson AE; Johansson SG Scand J Gastroenterol; 1995 Dec; 30(12):1172-7. PubMed ID: 9053970 [TBL] [Abstract][Full Text] [Related]
5. Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability. Playford RJ; MacDonald CE; Calnan DP; Floyd DN; Podas T; Johnson W; Wicks AC; Bashir O; Marchbank T Clin Sci (Lond); 2001 Jun; 100(6):627-33. PubMed ID: 11352778 [TBL] [Abstract][Full Text] [Related]
6. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man. Bjarnason I; Fehilly B; Smethurst P; Menzies IS; Levi AJ Gut; 1991 Mar; 32(3):275-7. PubMed ID: 1901563 [TBL] [Abstract][Full Text] [Related]
7. Comparison of indomethacin and nimesulide, a selective cyclooxygenase-2 inhibitor, on key pathophysiologic steps in the pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in the rat. Sigthorsson G; Jacob M; Wrigglesworth J; Somasundaram S; Tavares I; Foster R; Roseth A; Rafi S; Mahmud T; Simpson R; Bjarnason I Scand J Gastroenterol; 1998 Jul; 33(7):728-35. PubMed ID: 9712237 [TBL] [Abstract][Full Text] [Related]
8. COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice. Sigthorsson G; Simpson RJ; Walley M; Anthony A; Foster R; Hotz-Behoftsitz C; Palizban A; Pombo J; Watts J; Morham SG; Bjarnason I Gastroenterology; 2002 Jun; 122(7):1913-23. PubMed ID: 12055598 [TBL] [Abstract][Full Text] [Related]
9. Effect of glutamine on the intestinal permeability changes induced by indomethacin in humans. Hond ED; Peeters M; Hiele M; Bulteel V; Ghoos Y; Rutgeerts P Aliment Pharmacol Ther; 1999 May; 13(5):679-85. PubMed ID: 10233193 [TBL] [Abstract][Full Text] [Related]
10. Preventive effect of agaro-oligosaccharides on non-steroidal anti-inflammatory drug-induced small intestinal injury in mice. Higashimura Y; Naito Y; Takagi T; Tanimura Y; Mizushima K; Harusato A; Fukui A; Yoriki H; Handa O; Ohnogi H; Yoshikawa T J Gastroenterol Hepatol; 2014 Feb; 29(2):310-7. PubMed ID: 23980531 [TBL] [Abstract][Full Text] [Related]
11. Detection of naproxen-induced intestinal permeability change may be facilitated by adding a standardized meal but not by forming marker ratios. Oman H; Henriksson AE; Johansson SG; Blomquist L Scand J Gastroenterol; 1996 Dec; 31(12):1182-8. PubMed ID: 8976010 [TBL] [Abstract][Full Text] [Related]
13. Increased gap density predicts weakness of the epithelial barrier in vivo by confocal laser endomicroscopy in indomethacin-induced enteropathy. Shi S; Wang H; Gao H; Li Z; Chen FX; Zuo XL; Li YQ Dig Dis Sci; 2014 Jul; 59(7):1398-405. PubMed ID: 24573719 [TBL] [Abstract][Full Text] [Related]
14. Antiinflammatory drug-induced small intestinal permeability: the rat is a suitable model. Davies NM; Wright MR; Jamali F Pharm Res; 1994 Nov; 11(11):1652-6. PubMed ID: 7870685 [TBL] [Abstract][Full Text] [Related]